EPSO submission on plants produced by certain new genomic techniques
EPSO submitted its position on the impact of policy options regarding the legislation for plants produced by certain new genomic techniques (NGTs)
In the submission to the DG SANTE's public consultation, EPSO reiterated previous positions and pointed out that:
- In relation to NGTs, the current biosafety legislation is no longer fit for purpose and needs adaptation to scientific and technological progress.
- Since there is no difference between mutations produced using NGTs and classical mutagenesis, the same level of biosafety precautions should be applied.
- Sustainability should be managed on a system-level and not be used as a criterion solely and explicitly for NGT authorisation.
EPSO submission to the European Commission’s consultation on the impact assessment of policy options regarding the legislation for plants produced by certain new genomic techniques (NGTs). Read the full EPSO statement on the EPSO website.
Jens Sundström & Alan Schulman, EPSO Chairs WG Agricultural Technologies
Karin Metzlaff, EPSO Executive Director
EPSO, the European Plant Science Organisation, is an independent academic organisation currently representing 70 institutional members bringing together more than 200 research institutes, departments and universities from 31 countries in Europe and beyond.
EPSO’s mission is to improve the impact and visibility of plant science in Europe. EPSO’s top priorities are to provide advice on science policy towards a strategic approach and critical mass funding for basic and applied research across Europe, to coordinate research activities at the national and European levels – and beyond, and to facilitate the understanding of plant science.